Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Randomised Controlled Trial to Investigate the Efficacy of ANTOX (Vers) 1.2 and MGCT (Magnesiocard) for the Treatment of Hereditary Pancreatitis and Idiopathic Chronic Pancreatitis

NCT00142233 is registered in ClinicalTrials.gov with University Medicine Greifswald as lead sponsor.

NCT NCT00142233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00142233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Randomised Controlled Trial to Investigate the Efficacy of ANTOX (Vers) 1.2 and MGCT (Magnesiocard) for the Treatment of Hereditary Pancreatitis and Idiopathic Chronic Pancreatitis
Lead sponsor
University Medicine Greifswald
Phase
Phase 3
Overall status
Completed
Start date
June 6, 2005
Completion date
September 30, 2019
Enrollment
295 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatitis